La fibromatosi uterina: ipotesi eziopatogenetiche e strategie terapeutiche [PDF]
De Falco, Marianna
core +1 more source
Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment. [PDF]
Tanioka S +7 more
europepmc +1 more source
Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist. [PDF]
Sasatsu S +13 more
europepmc +1 more source
A Case of Familial Mediterranean Fever Diagnosed After Oral Administration of a Gonadotropin-Releasing Hormone (GnRH) Antagonist. [PDF]
Ueno H +4 more
europepmc +1 more source
Cost-effectiveness of dienogest compared to gonadotropin releasing hormone agonists for the management of endometriosis in Vietnam. [PDF]
Kieu MTT, Le MH, Nguyen CP.
europepmc +1 more source
Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research. [PDF]
Wang JY, Zhang Y, Ding J.
europepmc +1 more source
Response of gonadotropin-releasing hormone neurons from female mice to dynamic-clamp-simulated GABAergic conductances across development and after prenatal androgenization. [PDF]
Jaime J, DeFazio RA, Moenter SM.
europepmc +1 more source
Comparing the risk of cardiovascular disease between degarelix and gonadotropin-releasing hormone agonists:a systematic review and meta-analysis. [PDF]
Liu W +7 more
europepmc +1 more source
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. [PDF]
Siristatidis CS +3 more
europepmc +1 more source

